Blog

Construct Boundary Design: The 4 Problems Killing Your Protein Expression

Jan 9, 2026

You clone the full-length gene. Express it. Inclusion bodies. You try with tags. Still insoluble. You try insect cells. It expresses, but aggregates during purification. You truncate the C-terminus—guess where. The protein is now soluble but completely inactive.


Six months gone, and you still don't have a working construct.


The problem isn't your expression system or purification protocol. It's your construct boundaries. Defining where a protein starts and ends—what to include, what to truncate—is the single most important decision in structural biology.

Key Takeaways

  • 80-90% of construct failures are due to wrong boundaries

  • Main problems: Disordered termini (40%), flexible internal loops (20%), wrong domain boundaries (30%), bad tag placement (10%)

  • Average constructs tested: 5-15 per successful structure (traditional trial-and-error)

  • Cost of poor boundaries: $50-100K wasted per failed construct (6-12 months)

  • Modern solution: AI-driven boundary prediction reduces constructs tested from 10+ to 1-3

  • Success rate improvement: 60-80% first-construct success (vs 15-25% traditional)

What Are Construct Boundaries?

Construct boundaries define which residues you express and purify:

  • N-terminal boundary: Where does your protein start?

  • C-terminal boundary: Where does it end?

  • Internal boundaries: Which loops or domains do you include, truncate, or replace?


Example:

  • Full-length: Residues 1-450

  • Your construct: Residues 28-412 (N-terminal truncation of 27 residues, C-terminal truncation of 38 residues)

Why Boundaries Matter: The Goldilocks Principle

Include too much (disordered regions):

  • Flexible termini prevent crystallization

  • Disordered loops cause aggregation

  • PTMs create heterogeneity (blocks cryo-EM)

  • Result: Expresses but won't crystallize/freeze


Include too little (remove essential domains):

  • Protein loses stability (unfolds, aggregates)

  • Loses function (active site disrupted)

  • Result: Doesn't express, or is insoluble/inactive


Just right (structured core, minimal disorder):

  • Protein is stable, monodisperse

  • Crystallizes or forms good cryo-EM grids

  • Retains function

  • Result: Structure determination succeeds

Problem 1: Disordered N- and C-Terminal Tails (40% of Failures)

What it means: Your construct includes long (>15 residues) disordered regions at the termini.

Why It's a Problem

For crystallization:

  • Disordered residues adopt multiple conformations

  • Cannot form regular crystal lattice (requires identical packing)

  • Act as "entropy shields" (prevent crystal nucleation)


For cryo-EM:

  • Flexible termini create heterogeneity

  • 2D class averages become fuzzy

  • Reduces resolution


For biochemistry:

  • Disordered termini contain protease cleavage sites

  • Protein degrades during purification

  • Stability decreases (lower Tm)

How to Diagnose

1. AlphaFold pLDDT (per-residue confidence):

  • Blue (pLDDT >90): Well-ordered

  • Green (pLDDT 70-90): Likely ordered

  • Orange (pLDDT 50-70): Questionable

  • Red (pLDDT <50): Disordered


Rule of thumb: If >15 consecutive residues have pLDDT <50 at N- or C-terminus → Truncate


2. Disorder prediction tools:

  • IUPred: Score >0.5 = disordered

  • PrDOS: Probability >0.5 = disordered

  • DISOPRED3: Binary prediction


3. Sequence composition:

  • Disordered regions enriched in: Gly, Ser, Pro, Glu, Lys, Gln

  • Structured regions enriched in: Trp, Phe, Tyr, Ile, Val, Leu, Cys

  • Calculate composition: >40% disorder-promoting → likely disordered


4. Homolog comparison:

  • Find crystal structures of homologs in PDB

  • Check what boundaries they used

  • Disordered termini often truncated in successful structures

Example: Bacterial Enzyme

Full-length (1-380):

  • AlphaFold pLDDT:

    • Residues 1-22: pLDDT 30-50 (disordered)

    • Residues 23-355: pLDDT 85-95 (structured)

    • Residues 356-380: pLDDT 40-60 (disordered)


Test constructs:

  • Construct 1 (1-380, full-length): Expresses, won't crystallize

  • Construct 2 (23-355, truncate both): Expresses, crystallizes, 2.3 Å

  • Construct 3 (30-350, aggressive): Expresses, lower yield/stability


Winner: Construct 2 (remove disorder, keep structured core)

Problem 2: Flexible Internal Loops (20% of Failures)

What it means: Long (>15 residues) flexible loops connecting structured domains.

Why It's a Problem

For crystallization:

  • Flexible loops adopt multiple conformations

  • Prevent ordered crystal packing

  • Often proteolytically cleaved during crystallization


For cryo-EM:

  • Loops create local disorder

  • Reduce resolution in those regions

  • May cause preferred orientation

Common Locations

GPCRs:

  • Intracellular loop 3 (ICL3): 20-80 residues, highly flexible

  • Extracellular loop 2 (ECL2): Can be long and flexible


Multi-domain proteins:

  • Linkers between domains (5-50 residues)

  • Hinge regions (allow domain movement)


Enzymes:

  • Active site loops (flexible when substrate-free)

  • Regulatory loops

How to Diagnose

1. AlphaFold pLDDT analysis:

  • Internal loops with pLDDT <70 are likely flexible

  • Long loops (>20 residues) with pLDDT 70-85 may still cause problems


2. B-factors in homolog structures:

  • High B-factors (>80 Ų) indicate flexibility

  • These regions will be problematic


3. Proteolysis sensitivity:

  • Limited proteolysis (trypsin 1:1000, 30 min at RT)

  • Flexible loops cleaved preferentially

  • Mass spec identifies cleavage sites

The GPCR ICL3 Problem

Famous example: β2-adrenergic receptor

  • ICL3 (residues ~230-270): 40 residues, highly flexible

  • Wild-type: Cannot crystallize

  • Solution: Replace ICL3 with T4 lysozyme

  • Construct: Residues 1-229 + T4L + 271-350

  • Result: First GPCR crystal structure (2007, Nobel Prize 2012)


Why it worked:

  • T4L is rigid, well-behaved

  • Provides crystal contacts

  • Acts as "fiducial marker" for alignment

Problem 3: Wrong Domain Boundaries (30% of Failures)

What it means: You've truncated too aggressively and removed essential structural elements.

Why It's a Problem

Protein destabilization:

  • Removing C-terminal helix exposes hydrophobic core

  • Protein unfolds, aggregates

  • Lower Tm, reduced stability


Loss of function:

  • Active site disrupted

  • Cofactor binding site incomplete

  • Regulatory domain missing

How to Diagnose

1. AlphaFold structure inspection:

  • Check if truncation cuts through secondary structure

  • Bad: Truncate in middle of helix or β-strand

  • Good: Truncate in loop between elements


2. Domain architecture prediction:

  • Pfam: Identifies conserved domains

  • InterPro: Comprehensive domain annotation

  • Rule: Don't truncate within a Pfam domain


3. Homolog comparison:

  • Align with PDB homologs

  • Check if successful structures include the region you're removing


4. Stability testing:

  • Express truncated construct, measure Tm

  • Compare to longer construct

  • If ΔTm < -5°C → removed something important

Case Study: Removing Essential Helix

Target: Novel bacterial enzyme


Attempt 1:

  • Construct: Residues 1-320 (removed C-terminal 30 residues)

  • Expression: Inclusion bodies (completely insoluble)


Analysis:

  • AlphaFold structure: Residues 310-330 form amphipathic helix

  • Helix packs against core (stabilizes hydrophobic pocket)

  • Removing it exposes core → aggregation


Attempt 2:

  • Construct: Residues 1-340 (keep helix, remove last 10 disordered)

  • Expression: Soluble, stable

  • Crystallization: Success, 2.1 Å structure


Lesson: Even one helix can be critical. Respect secondary structure boundaries.

Problem 4: Wrong Fusion/Tag Placement (10% of Failures)

What it means: Affinity tag (His-tag, GST, MBP) or fusion protein placed where it disrupts folding or function.

Why It's a Problem

Fusion blocks active site:

  • Tag near substrate binding site

  • Protein cannot bind substrate

  • Appears inactive


Fusion disrupts oligomerization:

  • Protein normally forms dimer

  • Tag at dimerization interface prevents assembly

  • Monomeric protein is unstable


Fusion prevents membrane insertion:

  • For membrane proteins, N-terminal signal peptide required

  • Tag at N-terminus blocks signal peptide

  • Protein not inserted, aggregates

How to Diagnose

1. Check AlphaFold structure:

  • Visualize where N- and C-termini are located

  • Are they buried or surface-exposed?

  • Are they near active site or oligomerization interface?


2. Homolog comparison:

  • Where are termini in crystal structures?

  • Are they accessible?


3. Test both termini:

  • Construct A: His-tag at N-terminus

  • Construct B: His-tag at C-terminus

  • Test expression, solubility, activity

Tag Placement Rules

Rule 1: Surface-exposed termini are best

  • If AlphaFold shows N-terminus on surface → N-terminal tag okay

  • If buried → try C-terminal tag


Rule 2: Avoid active sites

  • Check where substrate binds

  • Place tag on opposite side


Rule 3: Avoid oligomerization interfaces

  • If protein forms dimer, check interface

  • Place tag away from contact surface


Rule 4: Use cleavable tags

  • For crystallography/cryo-EM: Remove tag after purification

  • Use TEV protease site, PreScission site, or SUMO

Multi-Domain Proteins: Special Considerations

Example: Full-length (1-520)

  • Domain 1 (catalytic): Residues 45-280

  • Linker (flexible): Residues 281-310

  • Domain 2 (regulatory): Residues 311-490

  • C-terminal tail (disordered): Residues 491-520


Good construct options:

  • Construct A: 45-280 (catalytic domain only)

  • Construct B: 45-490 (both domains, no disordered tail)

  • Construct C: 311-490 (regulatory domain only)


Bad construct options:

  • Construct D: 45-250 (truncates within catalytic domain) → Unstable

  • Construct E: 100-490 (removes part of catalytic domain) → Inactive


Key principle: Keep entire domains, remove linkers between them.

Membrane Proteins: Transmembrane Boundaries

The Challenge

  • Need to include entire transmembrane (TM) helices

  • Truncating in middle of TM helix → unstable, aggregates

  • Including too much intracellular/extracellular domain → flexible, prevents crystallization

How to Define TM Boundaries

1. Predict TM helices:

  • TMHMM: Classic tool, reliable

  • DeepTMHMM: Deep learning-based, more accurate

  • Orbion: Integrates TM prediction with structure


2. AlphaFold structure:

  • TM helices have high pLDDT (usually >90)

  • TM regions form distinct bundle


3. Hydropathy plot:

  • Kyte-Doolittle plot identifies hydrophobic regions (TM helices)

Boundary Rules for Membrane Proteins

Rule 1: Include complete TM helices

  • Don't truncate in middle of helix

  • Start/end in loop regions


Rule 2: Truncate flexible loops

  • Especially long loops (>20 residues)

  • GPCRs: ICL3 is classic target


Rule 3: Remove signal peptide

  • Signal peptide directs to ER

  • Not needed for recombinant expression

  • Predict with SignalP

Understanding Your Problem: Quick Diagnostic

Symptom

Likely Problem

Quick Test

AlphaFold has long orange/red termini

Disordered termini

Check pLDDT <50

Internal orange/red loops (>20 residues)

Flexible loops

Check pLDDT, compare homologs

Protein insoluble after truncation

Wrong domain boundary

Check if cut through helix/strand

Protein inactive after expression

Removed essential domain

Check Pfam, homolog structures

Low expression despite tag

Bad tag placement

Try opposite terminus

Membrane protein won't insert

Tag blocks signal peptide

Remove N-terminal tag

Key Takeaway

Construct boundary design isn't guesswork. It's a systematic engineering problem with predictable failure modes:

  1. Disordered termini (40%): Include flexible tails that prevent crystallization

  2. Flexible loops (20%): Internal disorder blocks structure determination

  3. Wrong domain boundaries (30%): Remove essential structural elements

  4. Bad tag placement (10%): Tags disrupt function or folding

Understanding your boundary problem is the first step to fixing it.